证券代码：002656 证券简称：*ST 摩登 公告编号：2025-083 摩登大道时尚集团股份有限公司 关于公司实际控制人及其关联方为子公司提供担保 暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 摩登大道时尚集团股份有限公司（以下简称"公司"）于2025年5月27日召开了 第六届董事会第十八次会议，审议通过了《关于公司实际控制人及其关联方为子公 司提供担保暨关联交易的议案》，具体情况如下： 一、接受关联担保的情况概述 为支持公司发展，公司实际控制人王立平先生及其关联方李玉娜、锐洋控股集 团有限公司（以下简称"锐洋控股"）拟为公司子公司辽宁沈鹏电力科技有限公司（以 下简称"沈鹏电力"）向银行申请的综合授信提供连带责任保证，担保额度为人民币 易不涉及关联定价的情况。 根据《深圳证券交易所股票上市规则》 第 1 号——主板上市公司规范运作》及《公司章程》等相关规定，王立平先生为公 司实际控制人，李玉娜女士、锐洋控股为公司实际控制人王立平先生的关联方，本 次交易构成关联交易。 公司实际控制人及其关联方为子公司提供担保暨关联交易的议案》，关联董事王 ...

Core Viewpoint - Anhui Fuhuang Steel Structure Co., Ltd. plans to acquire 100% equity of Hefei Zhongke Junda Vision Technology Co., Ltd. through a combination of issuing shares and cash payment, with a total transaction price of 1.14 billion yuan [3][18]. Group 1: Transaction Overview - The transaction involves purchasing 100% equity of Zhongke Vision from 17 counterparties, including Fuhuang Construction, Meng Jun, and Lü Panlang [3][5]. - The total transaction price is set at 1.14 billion yuan, with the cash component being 342 million yuan and the remaining 798 million yuan paid in shares [7][31]. - The company plans to raise up to 400 million yuan through issuing shares to no more than 35 specific investors, which will not exceed 30% of the total share capital before the transaction [3][15]. Group 2: Regulatory Compliance - The Supervisory Board has confirmed that the transaction complies with relevant laws and regulations, including the Company Law and Securities Law [2][22]. - The transaction is classified as a related party transaction, with the related supervisor Zhang Yanhong abstaining from voting [4][18]. - The proposal will be submitted for approval at the company's shareholders' meeting [5][20]. Group 3: Valuation and Pricing - The valuation date for the target asset is December 31, 2024, and the transaction price is based on the assessment results from a qualified asset appraisal agency [3][30]. - The share issuance price is set at 4.30 yuan per share, which is not lower than 80% of the average trading price over the previous 120 trading days [5][30]. - The assessment of Zhongke Vision's equity was conducted using both market and income approaches, with the income approach being selected for the final valuation [29][30]. Group 4: Fund Utilization - The raised funds will be used for cash payments related to the transaction, intermediary fees, and associated taxes [16][30]. - The company may opt to use self-raised funds for cash payments before the raised funds are available, with plans to replace them once the funds are secured [3][16]. Group 5: Shareholder Rights and Lock-up Period - Shares obtained through this transaction will be subject to a lock-up period, with specific terms varying by counterparty [10][11]. - The lock-up period for shares acquired by Fuhuang Construction and Meng Jun will last for 36 months, while other counterparties may have a 12 to 36-month lock-up depending on their investment duration [10][11]. Group 6: Financial Performance and Reporting - The transaction is not classified as a major asset restructuring, as the transaction amount does not exceed 50% of the company's relevant financial metrics [18][19]. - The company has conducted a self-examination of stock price fluctuations prior to the announcement, noting a cumulative increase of 31.06% over the last 20 trading days [26][30].

华泰联合证券有限责任公司 关于神州数码集团股份有限公司 与关联方共同投资暨关联交易的核查意见 华泰联合证券有限责任公司（以下简称"保荐人"）作为神州数码集团股份 有限公司（ （以下简称（ "神州数码" 《关于与关联方 "公司"）向不特定对象发行可转换公司债券及 进行持续督导的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交 易所股票上市规则》 《深圳证券交易所上市公司自律监管指引第 （ 13 号——保荐业 务》等相关法律、法规和规范性文件的要求，对神州数码与关联方共同投资暨关 联交易事项进行了核查，具体情况如下： 一、交易概述 神州数码集团股份有限公司（以下简称"公司"或"神州数码"）第十一届 董事会第十六次会议于 2025 年 5 月 26 日形成决议，审议通过了（ 共同投资暨关联交易的议案》，公司拟在未来 12 个月期间内以不超过 4.28 亿元 人民币通过集中竞价、协议转让或法律法规允许的其他形式增持神州数码控股有 限公司（以下简称"神州控股"）股票。本次增持前，公司已持有神州控股 公司董事长郭为先生为公司控股股东和实际控制人，为公司的关联方，其同 时持有神州控股股票，本次交易构成与郭为先生共同 ...

Overview - The company is providing a maximum guarantee amount of 50.75 million yuan to support the bond issuance of its associate, Huajin Securities, through a guarantee agreement with its controlling shareholder, Zhuhai Huafa Group [1][8]. Company and Financial Data - Huajin Securities has total assets of 11.282 billion yuan and net assets of 3.759 billion yuan as of December 31, 2024 [3]. - The company reported an operating income of 1.2674 billion yuan for the year 2024 and 1.3 billion yuan for the first quarter of 2025 [3]. - Zhuhai Huafa Group, the guarantor, has total assets of 729.285 billion yuan and net assets of 172.966 billion yuan as of December 31, 2024 [4]. Guarantee Agreement Details - The guarantee agreement allows for a maximum guarantee amount not exceeding 5.075 million yuan, which is 1.45% of the total bond issuance scale [5][6]. - The guarantee period is set for two years from the date of the guarantee responsibility [6]. - The agreement will be effective upon signature and seal by the legal representatives of both parties [7]. Purpose and Impact of the Transaction - The purpose of the related transaction is to lower the financing costs for Huajin Securities, thereby supporting its stable business development [8]. - The transaction is deemed reasonable and compliant, with no harm to the interests of the company or its shareholders, particularly minority shareholders [8]. - The company plans to increase its total external guarantee amount to 500 million yuan for 2025, which will represent approximately 33.66% of its audited net assets for 2024 [8]. Related Transactions - The total amount of related transactions that have occurred with the related party since the beginning of the year is 44.0336 million yuan [9]. Independent Directors' Opinion - The independent directors unanimously agreed that the provision of the guarantee aligns with the operational needs of the associate and complies with relevant laws and regulations [9].

证券代码：002267 证券简称：陕天然气 公告编号：2025-019 陕西省天然气股份有限公司 具体内容详见公司于2025年5月27日在指定媒体和巨潮资讯网披露的 《关于与陕西延长石油财务有限公司签署 <金融服务协议> 暨关联交易的 公告》（公告编号：2025-021）。 关联监事张珺、邢智勇、陈晓强对该议案回避表决。 表决结果：2票同意，0票反对，0票弃权。 同意将该议案提交股东大会审议。 三、备查文件 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 陕西省天然气股份有限公司（以下简称"公司"）第六届监事会第十六 次会议于 2025 年 5 月 23 日在公司调度指挥中心大楼 12 楼会议室召开。 召开本次会议的通知已于 2025 年 5 月 16 日以直接送达或电子邮件方式送 达各位监事。本次会议采用现场表决和通讯表决相结合的方式召开。监事 会主席张珺女士因公务原因无法出席现场会议，现场会议由半数以上监事 共同推举监事陈晓强先生主持，会议应参加表决监事 5 名，实际参加表决 监事 5 名。监事会主席张珺女士、职工监事杨子慧女士以通 ...

Group 1 - The company, Zhejiang Weihua New Materials Co., Ltd., plans to invest in Lansheng Biotechnology Group Co., Ltd. alongside related party Wu Jiangwei to enhance future profitability [1][6] - The investment involves the company acquiring 624,725 shares of Lansheng Biotechnology, representing 0.6907% of its total equity, for a consideration of 12,086,996 RMB [1][7] - Wu Jiangwei will also acquire shares from other parties, totaling 633,150 shares, for 12,250,000 RMB [1][7] Group 2 - Wu Jiangwei is the chairman and a controlling person of the company, making this investment a related party transaction, but it does not constitute a major asset restructuring [2][9] - The transaction has been approved by the company's board of directors and does not require shareholder approval [2][9] - The company has not engaged in other related party transactions with Wu Jiangwei in the past 12 months, aside from routine transactions [2][9] Group 3 - Lansheng Biotechnology was established on March 7, 2014, with a total registered capital of 90.45 million RMB, and operates in the agricultural chemicals sector [3][4] - The company has total assets of 194,556.71 million RMB and net assets of 127,027.73 million RMB as of December 31, 2024 [6] - The revenue for the year 2024 is projected to be 167,828.95 million RMB, with a net profit of 26,861.89 million RMB [6] Group 4 - The pricing of the shares is based on Lansheng's profitability and net asset scale, ensuring fairness and reasonableness in the transaction [6][8] - The agreement stipulates that the transfer price per share is 19.3477 RMB [7] - The investment is expected to improve the company's profitability and provide better returns for small and medium investors [8][9]

证券代码：603310 证券简称：巍华新材 公告编号：2025-032 浙江巍华新材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 浙江巍华新材料股份有限公司（以下简称"公司"或"巍华新材"）拟 与关联方吴江伟先生共同向兰升生物科技集团股份有限公司（以下简称"兰升生 物"）进行投资。其中，公司拟以现金方式受让石家庄鹏智创业投资中心（有限 合伙）（以下简称"鹏智创投"）所合法持有的兰升生物 624,725 股股份（占兰 升生物股本总额的 0.6907%），转让对价为 12,086,996 元。吴江伟先生拟以现金 方式分别从鹏智创投、关从巧女士受让其合法持有兰升生物的 180,900 股、 别为 3,500,000 元、8,750,000 元。 ? 吴江伟先生为公司董事长、实际控制人之一，根据《上海证券交易所股 《上海证券交易所上市公司自律监管指引第 5 号—交易与关联交易》 票上市规则》 二、关联人介绍 等规定，吴江伟先生为公司关联自然人，本次投资事项构成公司与关联方共同投 资的关联交易，但不 ...

本次会议的召集、召开和表决程序符合《公司法》、《上市公司独立董事管 理办法》等法律法规及《公司章程》的规定。全体独立董事以签名表决方式通过 如下议案： 表决情况：同意 3 票，反对 0 票，弃权 0 票。 证券简称：罗普斯金 独立董事专门会议 2025-004 中亿丰罗普斯金材料科技股份有限公司 第六届董事会独立董事 2025 年第四次专门会议决议 中亿丰罗普斯金材料科技股份有限公司（以下简称"公司"）于2025年5月 人。全体独立董事共同推举朱雪珍女士主持本次会议。 独立董事认为：本次出售控股子公司股权事项系基于公司整体业务规划， 有助于公司聚焦核心业务，优化业务布局。本次关联交易定价参考评估结果由 交易双方协商确定，定价公允，不存在损害公司及公司股东，尤其是中小股东 利益的情况。我们一致同意公司出售子公司股权暨关联交易事项，并同意将该 议案提交公司第六届董事会第二十二次会议审议。 的议案》 证券简称：罗普斯金 独立董事专门会议 2025-004 （本页无正文，为《中亿丰罗普斯金材料科技股份有限公司第六届董事会独立董事 独立董事签名： 薛誉华 朱雪珍 殷新 中亿丰罗普斯金材料科技股份有限公司 独立董事专门会 ...

Group 1 - The second meeting of the supervisory board of Zhejiang New Energy Investment Group Co., Ltd. was held on May 26, 2025, via communication, with all three supervisors present [1][2] - The supervisory board approved the proposal regarding the acquisition of a 29% stake in Zhejiang Zheneng Fuyang Chang'an Pumped Storage Co., Ltd. and related party transactions, concluding that it would not adversely affect the company's financial and operational status [1][2] - The board confirmed that the related party transaction complies with relevant laws and regulations, adhering to principles of openness, fairness, and justice, and does not harm the interests of the company and all shareholders, especially minority shareholders [1][2] Group 2 - The voting results for the proposal were unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] - The decision and related documents are available for review on the Shanghai Stock Exchange website [2] - The supervisory board takes legal responsibility for the truthfulness, accuracy, and completeness of the announcement [1]

Core Viewpoint - The recent change in the shareholding structure of Bluestar Medical has raised concerns among investors regarding potential interests transfer and the implications of the new indirect controlling shareholder, Langhui Chemical [3][4][5] Group 1: Shareholding Changes - Langhui Chemical has acquired a controlling stake in Bluestar Medical's major shareholder, Zibo Bluestar Investment, through a capital increase, diluting the stake of Bluestar Group from 98% to 47.0013% [5][6] - Despite the change in indirect control, the actual controller, Li Zhenping, remains unchanged, and the company asserts that this does not affect the control or business structure of Bluestar Medical [5][6][9] Group 2: Financial Performance and Transactions - Langhui Chemical, previously a loss-making subsidiary, has transformed into a leading enterprise in the plasticizer and resin sector, with revenues of approximately 12.15 billion, 12.69 billion, and 13.42 billion from 2022 to 2024 [6][11] - Bluestar Medical has reported continuous losses over the past three years, with revenues of approximately 4.9 billion, 4.93 billion, and 6.25 billion, and net losses of approximately 372 million, 568 million, and 446 million during the same period [11] Group 3: Supply Chain and Procurement - Langhui Chemical has been the largest supplier for Bluestar Medical over the past three years, with procurement amounts of approximately 499 million, 496 million, and 577 million, accounting for 15.27%, 12.88%, and 12.52% of total annual procurement [9][10] - Bluestar Medical plans to procure approximately 635 million from Langhui Chemical in 2025, which is significantly higher than from other suppliers, indicating a reliance on this supplier despite the commitment to reduce related transactions [10][11]